Neogenomics Inc Revenue Growth Rates (NEO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Neogenomics Inc   (NASDAQ: NEO)
    Sector • Technology    Industry • IT Infrastructure
   Industry • IT Infrastructure
   Sector • Technology
 

NEO's Revenue Growth by Quarter and Year

Neogenomics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/NEO/growth
https://api.csimarket.com/api/v1/companies/NEO/fundamentals
https://api.csimarket.com/api/v1/companies/NEO/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
NEO Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 209.25
2nd Quarter June 201.66
1st Quarter March 185.86
FY 596.77

NEOs Annual Revenue
Neogenomics Inc 's Revenue in the fiscal year 2025 $ 727.29 millions
Neogenomics Inc 's Revenue in the fiscal year 2024 $ 660.10 millions
Neogenomics Inc 's Revenue in the fiscal year 2023 $ 591.60 millions
Neogenomics Inc 's Revenue in the fiscal year 2022 $ 509.73 millions
Neogenomics Inc 's Revenue in the fiscal year 2021 $ 484.33 millions




NEO Revenue third quarter 2026 Y/Y Growth Comment
Neogenomics Inc reported Revenue increase of 11.63% year on year in the third quarter 2026, to $ 209.25 millions, this is lower than Neogenomics Inc 's recent average Revenue improvement of 24.69%.

Looking into third quarter 2026 results within IT Infrastructure industry 34 other companies have achieved higher Revenue growth. While Neogenomics Inc ' s Revenue growth of 11.63% ranks overall at the positon no. 2438 in the third quarter 2026.


NEO Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 11.63 %
2nd Quarter June 11.25 %
1st Quarter March 11.13 %
FY   -

Financial Statements
Neogenomics Inc 's third quarter 2026 Revenue $ 209.25 millions NEO's Income Statement
Neogenomics Inc 's third quarter 2025 Revenue $ 187.45 millions Quarterly NEO's Income Statement


NEO Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3.77 %
2nd Quarter June 8.5 %
1st Quarter March -2.86 %
FY (Year on Year)   -


Back to NEO Growth rate Comparisons >> Back to NEO Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
IT Infrastructure Industry #35
Technology Sector #394
Overall #2438

Revenue Y/Y Growth Statistics
High Average Low
144.57 % 24.69 % 0.13 %
(Dec 31 2016)   (Jun 30 2022)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
IT Infrastructure Industry #35
Technology Sector #394
Overall #2438
Revenue Y/Y Growth Statistics
High Average Low
144.57 % 24.69 % 0.13 %
(Dec 31 2016)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Neogenomics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
118.86 % 6.15 % -17.97 %
(Mar 31 2016)  


NEO's III. Quarter Q/Q Revenue Comment
Neogenomics Inc achieved in the III. Quarter 2026 below company average Revenue growth of 3.77% quarter on quarter, to $ 209.25 millions.

Although the III. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the III. Quarter surge, eclipses the 3.41% growth in the III. Quarter a year ago

Within IT Infrastructure industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Neogenomics Inc 's Revenue growth quarter on quarter, overall rank is 906.


Revenue Q/Q Growth Company Ranking
Within: No.
IT Infrastructure Industry #15
Technology Sector #128
Overall #906
Revenue Q/Q Growth Company Ranking
Within: No.
IT Infrastructure Industry #15
Technology Sector #128
Overall #906
Revenue Q/Q Growth Statistics
High Average Low
118.86 % 6.15 % -17.97 %
(Mar 31 2016)  


NEO's III. Quarter Q/Q Revenue Comment
Neogenomics Inc achieved in the III. Quarter 2026 below company average Revenue growth of 3.77% quarter on quarter, to $ 209.25 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 3.41% in the III. Quarter a year ago.

Within IT Infrastructure industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Neogenomics Inc 's Revenue growth quarter on quarter, overall rank is 906.


Neogenomics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 788.12
Y / Y Revenue Growth (TTM) 11.13 %
Year on Year Revenue Growth Overall Ranking # 1481
Seqeuential Revenue Change (TTM) 2.85 %
Seq. Revenue Growth (TTM) Overall Ranking # 2438


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Neogenomics Inc 's cumulative twelve months Revenue were $ 788 millions, company would post below average annual Revenue growth of 2.85% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Neogenomics Inc 's Revenue growth from the 201.66% growth in Jun 30 2026.

In the Technology sector 265 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 135 to 1481.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
IT Infrastructure Industry # 35
Technology Sector # 266
Overall # 1481

Revenue TTM Y/Y Growth Statistics
High Average Low
144.57 %
 24.69 %
0.13 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 394
S&P 500 # 2438
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Neogenomics Inc 's cumulative twelve months Revenue were $ 788 millions, company would post below average annual Revenue growth of 0.13% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Neogenomics Inc 's Revenue growth from the 201.66% growth in Jun 30 2026.

In the Technology sector 265 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 135 to 1481.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
IT Infrastructure Industry # 35
Technology Sector # 266
Overall # 1481

Revenue TTM Y/Y Growth Statistics
High Average Low
144.57 %
24.69 %
0.13 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 35
Sector # 394
S&P 500 # 2438




Other Revenue Growth
IT Infrastructure Industry Revenue Growth Trends and Statistics
Technology Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NEO's Revenue Growth Ratio versus IT Infrastructure Industry, Technology Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Technology SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Knowles Corporation20.34%$ 20.340 millions
Alkami Technology Inc 20.30%$ 20.304 millions
Red Violet Inc 20.22%$ 20.223 millions
Twilio Inc 19.96%$ 19.957 millions
Pdf Solutions Inc19.64%$ 19.643 millions
Avepoint Inc 19.64%$ 19.639 millions
Nxp Semiconductors N v 19.32%$ 19.319 millions
Smith Micro Software Inc 19.14%$ 19.140 millions
Benchmark Electronics Inc 19.13%$ 19.131 millions
Procore Technologies Inc 19.00%$ 18.996 millions
Allient Inc18.97%$ 18.974 millions
Microsoft Corporation18.80%$ 18.804 millions
Nano Dimension Ltd 18.71%$ 18.714 millions
Dirtt Environmental Solutions Ltd18.60%$ 18.602 millions
Appfolio Inc 18.58%$ 18.583 millions
Corning Inc18.41%$ 18.415 millions
Agilysys Inc 18.23%$ 18.227 millions
Mayville Engineering Company inc 18.05%$ 18.050 millions
Transcat Inc18.01%$ 18.011 millions
Light and Wonder Inc 17.95%$ 17.955 millions
Pubmatic Inc 17.79%$ 17.792 millions
Impinj Inc 17.58%$ 17.576 millions
Workiva Inc17.51%$ 17.505 millions
Varonis Systems Inc 17.37%$ 17.366 millions
Ametek Inc 17.31%$ 17.313 millions
Hubspot Inc 17.13%$ 17.128 millions
Airgain Inc 16.88%$ 16.879 millions
Intapp Inc 16.16%$ 16.157 millions
Par Technology Corporation15.98%$ 15.982 millions
Ibex Limited15.91%$ 15.906 millions


About Neogenomics Inc Revenue Growth Rates (NEO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Neogenomics Inc (CIK 1077183).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001077183-26-000079
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Neogenomics Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.